2nd Quarter - Report

JEFFREY J. KIMBELL & ASSOCIATES, INC. for ACELRX PHARMACEUTICALS, INC.

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$50,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 20, 2022 $50,000 Replaced
2nd Quarter - Termination Jul 20, 2022 $50,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

FDA drug approval process; Issues related to the opioid epidemic

LobbyistCovered position, as disclosed
JOHN HERZOG Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President
KENNETH LEE HODGE —
JEFFREY J KIMBELL —
JODIE LOCKHART New —
JOHN R RAY Legislative Assistant, Rep. Mike Kelly
DAVID RUDLOFF —
KEITH STUDDARD Legislative Director, Rep. Marsha Blackburn

Contacted: HOUSE OF REPRESENTATIVES

Defense DEF

Issues related to Defense Health Agency

LobbyistCovered position, as disclosed
JOHN HERZOG Health Aide, Sen. Lamar Alexander; Special Assistant to the Assistant to the President for Legislative Affairs, Executive Office of the President
KENNETH LEE HODGE —
JEFFREY J KIMBELL —
JODIE LOCKHART —
JOHN R RAY Legislative Assistant, Rep. Mike Kelly
DAVID RUDLOFF —
KEITH STUDDARD Legislative Director, Rep. Marsha Blackburn

Contacted: HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.